Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Sep-24 9:20 PM View:  | Travere Therapeutics, Inc. (TVTX) | 09-Sep-24 | Sale (Planned) | 4,387 | $11.52 | $50,538.20 | (5%) 88.84K to 84.45K | |
| 09-Sep-24 9:20 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Sep-24 | Grant | 6,750 | -- | -- | 8% 82.09K to 88.84K | |
| 02-Feb-24 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Feb-24 | Sale | 2,174 | $8.53 | $18,547.70 | (3%) 85.48K to 83.31K | |
| 02-Feb-24 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Feb-24 | Sale (Planned) | 2,590 | $8.86 | $22,947.40 | (3%) 83.31K to 80.72K | |
| 02-Feb-24 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-24 | Grant | 25,000 | -- | -- | 41% 60.48K to 85.48K | |
| 25-Jan-24 4:10 PM View: | Travere Therapeutics, Inc. (TVTX) | 23-Jan-24 | Sale (Planned) | 2,062 | $8.96 | $18,475.50 | (3%) 62.55K to 60.48K | |
| 05-Sep-23 8:13 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Sep-23 | Sale (Planned) | 1,815 | $14.71 | $26,698.70 | (3%) 62.99K to 61.17K | |
| 05-Sep-23 8:13 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Aug-23 | Grant | 3,300 | -- | -- | 6% 59.69K to 62.99K | |
| 12-May-23 4:09 PM View: | Travere Therapeutics, Inc. (TVTX) | 10-May-23 | Sale (Planned) | 825 | $16.59 | $13,686.80 | (1%) 60.04K to 59.21K | |
| 02-Feb-23 7:08 PM View: | Travere Therapeutics, Inc. (TVTX) | 01-Feb-23 | Sale (Planned) | 2,590 | $22.25 | $57,627.50 | (4%) 62.63K to 60.04K | |
| 02-Feb-23 7:08 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-23 | Grant | 20,250 | -- | -- | 48% 42.38K to 62.63K | |
| 26-Jan-23 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 24-Jan-23 | Sale (Planned) | 2,062 | $21.50 | $44,333.00 | (5%) 44.44K to 42.38K | |
| 12-May-22 8:49 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-22 | Sale (Planned) | 1,563 | $21.71 | $33,940.30 | (3%) 45.23K to 43.67K | |
| 02-Feb-22 4:19 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-22 | Grant | 9,840 | -- | -- | 27% 36.52K to 46.36K | |
| 02-Feb-22 4:19 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-22 | Sale (Planned) | 1,125 | $27.40 | $30,825.00 | (2%) 46.36K to 45.23K | |
| 26-Jan-22 4:37 PM View: | Travere Therapeutics, Inc. (TVTX) | 24-Jan-22 | Market Sale (Planned) | 1,875 | $24.98 | $46,837.50 | (5%) 38.4K to 36.52K | (12%) |
| 12-Jan-22 4:06 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-Jan-22 | Sale (Planned) | 2,500 | $27.40 | $68,500.00 | (6%) 40.9K to 38.4K | |
| 12-Jan-22 4:06 PM View: | Travere Therapeutics, Inc. (TVTX) | 10-Jan-22 | Grant | 5,000 | -- | -- | 14% 35.9K to 40.9K | |
| 13-May-21 4:13 PM View: | Travere Therapeutics, Inc. (TVTX) | 12-May-21 | Market Sale (Planned) | 1,562 | $19.46 | $30,396.50 | (5%) 33.27K to 31.71K | < 1% |
| 13-May-21 4:13 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-21 | Market Sale (Planned) | 1,563 | $19.14 | $29,915.80 | (4%) 34.83K to 33.27K | (4%) |
| 18-Feb-21 6:26 PM View: | Travere Therapeutics, Inc. (TVTX) | 18-Feb-21 | Market Sale (Planned) | 1,250 | $28.67 | $35,837.50 | (3%) 36.08K to 34.83K | (1%) |
| 18-Feb-21 6:26 PM View: | Travere Therapeutics, Inc. (TVTX) | 17-Feb-21 | Market Sale (Planned) | 1,250 | $27.35 | $34,187.50 | (3%) 37.33K to 36.08K | (6%) |
| 09-Feb-21 4:30 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-Feb-21 | Market Sale (Planned) | 2,250 | $31.58 | $71,055.00 | (6%) 39.58K to 37.33K | 2% |
| 09-Feb-21 4:30 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Feb-21 | Market Sale (Planned) | 2,250 | $31.41 | $70,672.50 | (5%) 41.83K to 39.58K | (1%) |
| 05-Feb-21 4:49 PM View: | Travere Therapeutics, Inc. (TVTX) | 03-Feb-21 | Grant | 4,500 | -- | -- | 12% 37.33K to 41.83K | |
| 03-Feb-21 9:32 PM View: | Travere Therapeutics, Inc. (TVTX) | 03-Feb-21 | Market Sale (Planned) | 3,625 | $28.91 | $104,799.00 | (9%) 40.96K to 37.33K | < 1% |
| 02-Feb-21 9:23 PM View: | Travere Therapeutics, Inc. (TVTX) | 02-Feb-21 | Market Sale (Planned) | 3,625 | $30.75 | $111,469.00 | (8%) 47.08K to 43.46K | |
| 02-Feb-21 9:23 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-21 | Grant | 5,000 | -- | -- | 13% 39.58K to 44.58K | |
| 25-Jan-21 8:58 PM View: | Travere Therapeutics, Inc. (TVTX) | 21-Jan-21 | Grant | 15,000 | -- | -- | 61% 24.58K to 39.58K | |
| 17-Nov-20 9:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 16-Nov-20 | Market Sale (Planned) | 2,500 | $23.96 | $59,900.00 | (9%) 26.59K to 24.09K | |
| 13-Nov-20 9:25 PM View: | Travere Therapeutics, Inc. (TVTX) | 13-Nov-20 | Market Sale (Planned) | 2,500 | $23.62 | $59,056.00 | (9%) 29.09K to 26.59K | |
| 13-Nov-20 9:25 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-Nov-20 | Grant | 5,000 | -- | -- | 21% 24.09K to 29.09K | |
| 23-Sep-20 8:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 23-Sep-20 | Market Sale (Planned) | 1,500 | $18.48 | $27,720.00 | (6%) 25.59K to 24.09K | (5%) |
| 22-Sep-20 9:20 PM View: | Travere Therapeutics, Inc. (TVTX) | 22-Sep-20 | Market Sale (Planned) | 1,500 | $18.59 | $27,885.00 | (6%) 27.09K to 25.59K | |
| 22-Sep-20 9:20 PM View: | Travere Therapeutics, Inc. (TVTX) | 18-Sep-20 | Grant | 3,000 | -- | -- | 12% 24.09K to 27.09K | |
| 13-May-20 9:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 12-May-20 | Market Sale | 527 | $16.98 | $8,950.73 | (2%) 24.83K to 24.31K | |
| 13-May-20 9:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 12-May-20 | Market Sale (Planned) | 812 | $17.16 | $13,933.90 | (3%) 24.31K to 23.49K | |
| 13-May-20 9:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-20 | Market Sale (Planned) | 813 | $14.95 | $12,154.30 | (3%) 25.65K to 24.83K | |
| 12-Mar-20 7:45 PM View: | Travere Therapeutics, Inc. (TVTX) | 10-Mar-20 | Market Sale (Planned) | 3,250 | $14.87 | $48,327.50 | (11%) 28.9K to 25.65K | |
| 09-Mar-20 9:08 PM View: | Travere Therapeutics, Inc. (TVTX) | 05-Mar-20 | Grant | 3,250 | -- | -- | 13% 25.65K to 28.9K | |
| 19-Feb-20 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 18-Feb-20 | Market Sale (Planned) | 1,250 | $16.55 | $20,687.50 | (5%) 26.9K to 25.65K | |
| 19-Feb-20 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 14-Feb-20 | Market Sale (Planned) | 1,250 | $16.72 | $20,900.00 | (4%) 28.15K to 26.9K | |
| 31-Jan-20 8:19 PM View: | Travere Therapeutics, Inc. (TVTX) | 31-Jan-20 | Grant | 9,000 | -- | -- | 49% 18.18K to 27.18K | |
| 16-May-19 9:36 PM View: | Travere Therapeutics, Inc. (TVTX) | 15-May-19 | Market Sale (Planned) | 812 | $17.76 | $14,421.10 | (4%) 19.0K to 18.18K | (5%) |
| 16-May-19 9:36 PM View: | Travere Therapeutics, Inc. (TVTX) | 14-May-19 | Market Sale (Planned) | 813 | $17.78 | $14,455.10 | (4%) 19.81K to 19.0K | (< 1%) |
| 10-May-19 9:41 PM View: | Travere Therapeutics, Inc. (TVTX) | 09-May-19 | Grant | 6,000 | -- | -- | 43% 13.81K to 19.81K | |
| 20-Feb-19 7:58 PM View: | Travere Therapeutics, Inc. (TVTX) | 19-Feb-19 | Market Sale (Planned) | 1,250 | $21.52 | $26,900.00 | (8%) 15.06K to 13.81K | 2% |
| 20-Feb-19 7:58 PM View: | Travere Therapeutics, Inc. (TVTX) | 15-Feb-19 | Market Sale (Planned) | 1,250 | $21.44 | $26,800.00 | (8%) 16.31K to 15.06K | (< 1%) |
| 13-Feb-19 8:49 PM View: | Travere Therapeutics, Inc. (TVTX) | 12-Feb-19 | Market Sale (Planned) | 992 | $21.50 | $21,328.00 | (6%) 17.0K to 16.01K | (3%) |
| 13-Feb-19 8:49 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-Feb-19 | Market Sale (Planned) | 993 | $21.38 | $21,230.30 | (6%) 17.99K to 17.0K | (< 1%) |